HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer. [electronic resource]
Producer: 20160706Description: 476-84 p. digitalISSN:- 1436-3305
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Esophageal Neoplasms -- drug therapy
- Esophagogastric Junction -- pathology
- Humans
- Immunohistochemistry
- In Situ Hybridization, Fluorescence
- Molecular Targeted Therapy
- Receptor, ErbB-2 -- analysis
- Stomach Neoplasms -- drug therapy
- Trastuzumab -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.